-
Mashup Score: 0| Memorial Sloan Kettering Cancer Center - 1 year(s) ago
The Rockefeller Outpatient Pavilion at 53rd Street is temporarily closed following an isolated fire in a non-clinical area on Sunday evening. The fire was quickly extinguished by the FDNY, which has inspected the building and declared that it is safe and structurally sound. However, because of water damage, the patient elevators are not operating. We will not see patients in the building until…
Categories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 6MSK Research Highlights July 17, 2023 - 1 year(s) ago
New MSK research identified a way to reduce toxicity in CAR T cell therapy; discovered a division of labor in DNA repair that suggests a possible therapeutic strategy for certain cancers; developed a new method to enable imaging of two PET tracers simultaneously; found biomarkers that could help predict outcomes in HER2-positive metastatic esophagogastric cancer; and made progress toward…
Categories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0July 12, 2023: International Precision Oncology Tumor Board: MSK & Sir HN Reliance Foundation Hospital: Targeting the BRAF Pathway - 1 year(s) ago
July 12, 2023: International Precision Oncology Tumor Board – Targeting the BRAF Pathway: MSK & Sir HN Reliance Foundation Hospital Interpreting results from next-generation genomic sequencing of cancer, and identifying the right drug for the right patient, is a challenge for many cancer specialists today. Join leading global experts for a new educational series from MSK, where we’ll take a deep…
Categories: Latest Headlines, Oncologists2Tweet
-
Mashup Score: 3July 12, 2023: International Precision Oncology Tumor Board: MSK & Sir HN Reliance Foundation Hospital: Targeting the BRAF Pathway - 1 year(s) ago
July 12, 2023: International Precision Oncology Tumor Board – Targeting the BRAF Pathway: MSK & Sir HN Reliance Foundation Hospital Interpreting results from next-generation genomic sequencing of cancer, and identifying the right drug for the right patient, is a challenge for many cancer specialists today. Join leading global experts for a new educational series from MSK, where we’ll take a deep…
Categories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 6
When Dr. Urvi Shah was diagnosed with Hodgkin lymphoma in 2016 during her first year as a hematology-oncology fellow, she heard lots of recommendations from friends and family about what she should and shouldn’t eat.
Categories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0
When Dr. Urvi Shah was diagnosed with Hodgkin lymphoma in 2016 during her first year as a hematology-oncology fellow, she heard lots of recommendations from friends and family about what she should and shouldn’t eat.
Categories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 1Summer Pipeline Program - 1 year(s) ago
This eight-week research program offers students from underrepresented groups in medicine the opportunity to gain research experience under the mentorship of MSK faculty.
Categories: Hem/Oncs, Latest HeadlinesTweet-
"Patching the pipeline should not be the responsibility of only those it affects. Everyone should be involved for the betterment of society & to best care for patients." I had the pleasure of working with Student Doctor Anglade last year @MSKCancerCenter https://t.co/6XcOp70dIU https://t.co/BUvDUOeRoJ
-
-
Mashup Score: 2MSK Awards & Appointments June 2023 - 1 year(s) ago
Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments.
Categories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 3MSK Research Highlights, June 29, 2023 - 1 year(s) ago
New MSK research discovered ferroptosis regulators that suggest therapeutic opportunities against hormone receptor-positive cancers; examined how tumor-associated macrophages might be turned against cancer; acquired new insights into joint inflammation in rheumatoid arthritis; developed a systems-level platform called epichaperomics to map changes in interactors among thousands of proteins…
Categories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 4Exposing a Cancer Cell’s Weakness - 1 year(s) ago
MSK has developed an arsenal of tests that are at the front lines of precision treatments. They target the structure of proteins that cause cancer, offering people new hope.
Categories: Hem/Onc News and Journals, Latest HeadlinesTweet-
How 2 MSK-developed #cancer #genetictests - MSK-IMPACT® (which uses a tissue biopsy to identify the best treatment) & MSK-ACCESS® (a blood test to detect a patient's response to treatment) - have helped revolutionize the way cancer is treated worldwide: https://t.co/V4ml1fDJe9 https://t.co/HVpsweiKCs
-
The Rockefeller Outpatient Pavilion at 53rd Street is temporarily closed following an isolated fire in a non-clinical area on Sunday evening. Patients scheduled for appointments this week in the 53rd Street facility will be rescheduled. Learn more here: https://t.co/JKsFlEasWS